The testosterone-androgen receptor pathway inhibits the cell proliferation of seminal vesicle gland epithelial cells.
(A) The localization of the androgen receptor (AR; NR3C4) in seminal vesicle of control (Ctrl) mice and those treated with flutamide (Fult). Scale bar=50 µm for left panel and 20 µm for right panel in each group. (B,C) Cell proliferation and apoptosis in seminal vesicle of control (Ctrl) mice and those treated with flutamide (Fult): (B) Representative images of Ctrl and Flut staining for Ki67 (top) and TUNEL (bottom). Scale bar=20 µm. (C) Percentage of Ki67 positive cells (top) and TUNEL positive (bottom) in Ctrl and Flut-treated seminal vesicle sections. (D) Experimental design to evaluate the effects of testosterone on the proliferation of seminal vesicle epithelial cells in vitro. The epithelial cells were culutured with or without testosterone for 8 days. (E) Growth curves of seminal vesicle epithelial cells that cultured with 0, 1, 10 and 100 ng/mL of testosterone. (F,G) Cell cycle status was determined by flow cytometry. Data are mean ± SEM. n=3-5 mice or independent replicates. Each replicate experiments with 3-6 wells containing pooled cells from 3-5 mice. Significance was tested in comparison to Ctrl using Student’s t-test. The cell proliferation data were compared to Ctrl by Dunnett’s test.